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We analyzed parameters influencing HIV-1 infectibility of cells of the monocyte/macrophage lineage (MO/MAC) isolated
from different healthy donors. The proportion of in vitro-infected cells and replication kinetics in different donor MAC ranged
from 0.03 to 99% p24 antigen-positive MAC and from undetectable RT activity up to 5 3 106 cpm/ml/90 min, respectively. As
a quantitative measurement for HIV-1 susceptibility of donor MO/MAC, we determined TCID50 values of defined virus stocks
which varied up to 3000-fold depending on the donor MAC used for titration. As host factors which may influence the viral
infection we determined the expression of virus receptors CD4, CCR5, CXCR4, and CCR3 as well as the secretion of the
natural ligands of CCR5, which altogether showed no correlation with HIV-1 infectibility of the cells. Moreover, other
MO-derived secretory factors which might affect viral infection of these cells could be excluded. Furthermore, expression of
maturation-related antigens CD14, CD16, HLA-DR, and MAX.1/CPM was determined. Analysis of the reverse transcription
process revealed that restricted HIV-1 infection was reflected by highly reduced or even undetectable full-length HIV-1 DNA
formation, although early and intermediate transcripts appeared, suggesting that viral replication is blocked after entry at the
level of early reverse transcription. © 2001 Academic Press
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Monocytes/macrophages (MO/MAC) as major target
cells and reservoir for HIV-1 harbor the virus in lymph
nodes and many other organs, such as lung or the
central nervous system, where HIV-1 is primarily located
in macrophage-like cells (i.e., alveolar macrophages and
microglia) (Gartner et al., 1986; Housset et al., 1990;
icholson et al., 1986; Smith et al., 1997; Toossi et al.,
997; von Briesen et al., 1990). Infection of these cells
esults in altered cellular functions in the macrophage
opulation (Levy, 1993; Moses et al., 1998; Weiss, 1993),
hich ultimately lead to several clinical manifestations of
isease, including encephalopathy, vacuolar myelopathy,
neumocystis, and lymphatic hyperplasia (Eilbott et al.,
989; Gendelman et al., 1989; Sierra-Madero et al., 1994;
tevenson and Gendelman, 1994).
In addition to their function in the pathogenesis of the
isease there is evidence that cells of the monocyte/
acrophage lineage are vectors for mucosal transmis-
ion of HIV-1 (Milman and Sharma, 1994; Zacharopoulos
t al., 1997). Also, MO/MAC are a latent reservoir for
IV-1 (Embretson et al., 1993). Thus, parameters which
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Virology and Cell Biology, Georg-Speyer-d
aus, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt am Main, Ger-
any. Fax: 149-69-63395-297. E-mail: briesen@em.uni-frankfurt.de.
31nfluence the ability of this cell lineage to replicate HIV-1
ay determine progression of the disease. Several viral
actors which are related to the development of immu-
odeficiency have been identified, including genotype
nd biological phenotype of the virus. For example, mu-
ations in the nef–LTR region of the HIV-1 genome reduce
he immunosuppressive effect of the virus (Deacon et al.,
995; Kirchhoff et al., 1995; Salvi et al., 1998). Disease
rogression is often accompanied by a switch in core-
eptor usage due to changes in the env sequences
Scarlatti et al., 1997). On the other hand, the role of host
enetic factors with respect to HIV-1 infection is less well
nvestigated. However, there is some evidence that the
ost’s HLA types have a predictive value on disease
rogression, as combination of HLA antigens A1, Cw7,
8, and DR3 clearly predisposes to a more rapid pro-
ression (Kaslow et al., 1990). Dalgleish and colleagues
escribed a correlation between the expression of a T
ell receptor subfamily and HIV-1 infection (Dalgleish et
l., 1992). More recently, after discovery of the chemo-
ine receptors CCR5 and CXCR4 as main coreceptors for
IV-1, it became evident that mutations in the CCR5
ene, if homozygous, are correlated to resistance to
5-tropic HIV-1 (Dean et al., 1996; Liu et al., 1996; Sam-
on et al., 1996). In addition, it could be shown that
IV-1-infected individuals who are heterozygous for the
eletion mutation in the CCR5 gene have a slower rate of
isease progression (Dean et al., 1996; Michael et al.,
0042-6822/01 $35.00
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32 EISERT ET AL.1997; Zimmerman et al., 1997). Moreover, a genetic poly-
morphism of the untranslated regulatory region of the
SDF-1 gene, the ligand for the chemokine receptor
CXCR4, leads to a significantly delayed progression to
AIDS, if the HIV-1-infected individual is homozygous for
this polymorphism (Winkler et al., 1998).
In early in vitro studies by Williams and Cloyd, periph-
ral blood mononuclear cells (PBMC) from different do-
ors showed variable susceptibility, with differences up
o 1000-fold (Williams and Cloyd, 1991). A limitation of
hese studies was the use of viral stocks which were
dapted to T cell lines. In contrast, Spira and Ho found a
aximum of only 40-fold variation in HIV-1 production in
onor PBMC, using low-passage primary isolates (Spira
nd Ho, 1995). In these studies no comparison of repli-
ation levels in different donor macrophages was per-
ormed. The latter has been studied by Cunningham and
oworkers comparing the replication of clinical blood-
erived HIV-1 strains in monocytes/macrophages de-
ived from pairs of both identical twins and age-matched
nrelated donors (URD) (Chang et al., 1996; Naif et al.,
999). Discordant patterns of HIV-1 replication kinetics
etween URD monocytes/macrophages contrasted with
oncordant patterns in identical twin cells, suggesting a
ost cell genetic effect on productive viral replication in
O/MAC.
Taken together, these findings suggest that host ge-
etic effects in combination with viral properties deter-
ine the susceptibility of an appropriate target cell for
IV-1 infection as well as the replicative potential of the
irus in the cell resulting in an overall productive infec-
ion. This viral/host interaction has marked implications
or the pathogenesis of the viral infection, as it has been
hown that HIV-1 viral load determines the progression
f the disease independent of the CD4 T lymphocyte
FIG. 1. HIV-1 infection of MAC derived from 30 different donors.
MO-derived MAC were infected with HIV-1D117III on day 7 after start of
culture for 24 h. On day 21 the percentage of p24-positive cells was
calculated and virus replication was monitored by determining reverse
transcriptase (RT) activities in 24-h supernatants (detection limit of RT
activity was approx 1000 cpm/ml/90 min).evel (Ho, 1998; Mellors et al., 1995).
In this study we investigated the infectibility of MO/AC from healthy donors by HIV-1 at different steps of
he viral life cycle. First, we determined virus production
nd the number of infected cells as well as the virus
mount produced per single infected cell. The suscepti-
ility of MO/MAC derived from individual donors was
uantified by determining the 50% tissue culture infective
ose (TCID50) of well-characterized virus isolates on cells
rom different donors. In addition, we focused on various
ost factors (e.g., virus receptor expression and secre-
ion of their natural ligands) which may influence the
nfectibility of MO/MAC on the level of virus entry. Fur-
hermore, HIV-1 infectibility of the cells was analyzed at
he level of reverse transcription (RT) by identification of
he various transcripts arising during RT reaction.
RESULTS
IV-1 infection and replication kinetics in different
onor macrophages
Monocyte-derived macrophages from 30 different do-
ors were infected with the primary HIV-1 isolate D117III
n day 7 after start of culture. On day 21 RT activities
ere determined in 24-h supernatants. As shown in Fig.
, extreme variations in RT activities were observed for
ndividual donor MO/MAC, ranging from negative values
p to 2 3 106 cpm/ml/90 min.
HIV-1 infectibility of donor MAC at the single-cell level
was determined by immunocytochemical staining with a
p24 monoclonal antibody. The percentage of p24-posi-
tive MAC was calculated in each individual culture. The
number of HIV-1 p24 antigen-expressing cells reflected
the variation found at the level of virus production, vary-
ing between 0.03 and 99% p24-positive cells (Fig. 1).
For further analysis, five donors reflecting the diverse
spectrum of virus replication patterns were selected. The
replication kinetics of HIV-1D117III was determined for all
ive donors in three individual experiments. For each
onor, a similar pattern of replication kinetics was found
n the independent experiments, as shown in Fig. 2. For
onor KS, rapid and high virus production was measured
ith values up to 5 3 106 cpm/ml/90 min on day 28 of
cultivation. In contrast, in MAC cultures derived from
donor MP, no RT activity was detected at any time point.
Intermediate RT activities were found for the other cell
donors. Only cells of donor TK reached high RT activities
but at later time points. Differences of virus replication
kinetics between donors MP, BH, TK, and KS were ana-
lyzed statistically by using the Friedman test. The four
kinetics of different donors were found to be significantly
different with P 5 0.01. In addition, production of p24
antigen in MAC cultures was measured. MAC of KS
reached a high level of p24 (33,000 pg/ml) in the culture
supernatant even at an early time point, whereas the
cultures derived from MAC of donor MP showed a max-
imal virus production on day 11 (20 pg/ml p24 antigen;
data not shown).
33CELLULAR FACTORS INFLUENCING HIV-1 REPLICATIONFIG. 2. HIV-1 replication in monocytes/macrophages. 7-day-old MO-derived MAC from different donors were infected with HIV-1D117III for 24 to 48 h
and the virus replication was monitored. The RT activity was always determined in supernatants of three independent parallel cultures of infected
MAC from five different donors at different time points after infection as described under Materials and Methods. Data presented are the means 6
SEM. Three representative kinetics, (A), (B), and (C), from HIV-1D117III-infected donor MAC derived from individual cell preparations are shown. The
kinetics of donors MP, BH, TK, and KS were found to be statistically different (P 5 0.01).
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34 EISERT ET AL.Next, the numbers of p24-positive cells derived from
the five selected donors were calculated by immunocy-
tochemistry 2 weeks after infection. Whereas MAC cul-
tures of donors BH, PR, TK, and KS reached levels be-
tween 10 and 30% positive cells, cultures of MP never
exceeded 0.03% p24-positive MAC (data not shown).
Figures 3A and 3B show MAC cultures of the two most
different donors, MP and KS, stained on day 21 with p24
monoclonal antibody, respectively.
The virus production at the single-cell level was de-
termined in 4 to 16 independent cultures of the individual
donors by measuring p24 antigen in culture superna-
tants within a 72-h interval and relating these values to
the number of HIV-1-positive cells as determined by
immunocytochemistry (Fig. 3C). The amount of p24 anti-
gen production per single infected macrophage did not
vary much between cultures derived from different do-
nors. Even for the two most different MAC donors, MP
and KS, equivalent virus production rates per infected
cells of 7.51 6 5.67 pg/cell/72 h for donor MP and 8.26 6
.67 pg/cell/72 h for donor KS were achieved. Statistical
nalysis using unpaired Student’s t test revealed no
ifferences between virus production rate of single HIV-
-infected donor cells (0.254 , P , 0.989).
To quantify the variation in susceptibility of the donor
AC for HIV-1, we determined the TCID50 of three defined
irus stocks on monocyte-derived macrophages derived
rom the five selected donors. Titration of HIV-1D117III re-
vealed up to 3000-fold differences between the MAC of
donors MP and KS (Table 1). The titration of the HIV-1D117III
virus stock on MAC derived from donors BH, PR, and TK
reached intermediate TCID50 levels. A similar pattern of
infectibility for the five different donor cells was obtained
if another macrophagotropic isolate (ADA-M) was used.
TCID50 values for ADA-M differed by a factor of up to 50
between MAC donors MP and KS. As expected, the
titration of the X4 strain HIV-1BRU on MAC revealed low
titers and the efficiency of infection of different MAC
cultures did not show the pattern of the M-tropic viruses.
TCID50 values of isolate BRU varied by a factor of about
(donors MP and TK).
onor-dependent differences in HIV-1 infectibility of
AC analyzed at the level of virus receptors, MAC-
pecific surface molecules, and soluble factors
The expression of CCR5 and other HIV-1 receptors on
he surface of the donor MAC was examined by flow
ytometry on day 7 of cultivation, which was the time
oint of in vitro infection. As shown in Fig. 4A, some
ifferences were found for the HIV-1 receptor CD4, but its
xpression level did not correlate with HIV-1 infectibility.
n particular, MAC of MP and KS, which showed the
trongest difference in HIV-1 infectibility, express nearlydentical amounts of CD4. The coreceptors CCR3, CCR5,
nd CXCR4 were expressed at similar levels on MAC of
t
The different donors. Moreover, MAC donors were ana-
yzed for their CCR5 genotype. Presence or absence of
he CCR5 D32 deletion was investigated by PCR. All five
onors were homozygous wild type for CCR5 as found by
FIG. 3. Immunocytochemical staining of HIV-1 p24 antigen in MAC of
donors MP (A) and KS (B) on day 21 of culture. (C) p24 antigen
concentration in the culture supernatants within a 72-h interval was
determined and the number of HIV-1-infected macrophages in each
individual culture was identified by immunocytochemical staining (for
details see Materials and Methods); p24 antigen production per single
HIV-1-infected macrophage was calculated and given as mean 6 SEM
(n 5 4 to 16). No statistical difference was found using unpaired
tudent’s t test (0.254 , P , 0.989).he detection of a single PCR amplificate of 547 bp.
herefore, differences in HIV-1 infectibility of the various
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35CELLULAR FACTORS INFLUENCING HIV-1 REPLICATIONdonor MAC could not be attributed to the D32 deletion in
CCR5. Furthermore, the chemokine secretion potential of
the donors’ MAC on day 8 after start of culture compris-
ing the ligands to CCR5, the b-chemokines MIP-1a and
ANTES, was analyzed. No correlation between the se-
retion of MIP-1a and RANTES and HIV-1 infectibility of
the cells was observed (data not shown).
To further address the differences of the donor MAC,
the expression of several typical MAC antigens was
analyzed (Fig. 4A). MAX.1, also known as carboxypepti-
dase M and a marker of mature MAC, was detected in
lower amounts on MAC with low HIV-1 infectibility (MP)
and in higher amounts on MAC with high infectibility (KS)
in this experiment and in two additional FACS analyses
based on independent blood collections of these donors.
However, in one experiment this difference was not ob-
served. The higher expression of CD14 in cells of donor
MP could be repeatedly confirmed in five independent
FACS analyses, of which one is shown in Fig. 4B. The
expression of another MAC maturation marker, CD16, is
similar on MAC of all donors, and also for HLA-DR
expression no correlation to HIV-1 infectibility was seen.
The influence of hematopoietic growth factors on
HIV-1 infection of donor MAC was analyzed in vitro.
Therefore, we cultivated the cells continuously under the
influence of M-CSF, GM-CSF, IL-3, or a mixture of all
three cytokines, for which mononuclear phagocytes have
surface receptors (Figs. 5A and 5B). If the cells derived
from KS were treated with M-CSF virus replication in-
creased up to fourfold. IL-3, GM-CSF, and the mixture of
the three cytokines had a inhibitory effect on virus rep-
lication. In contrast, virus replication in MO-derived MAC
from donor MP was not stimulated by M-CSF. Moreover,
the cultivation of these donor cells under the influence of
these cytokines did not alter the replication kinetics,
T
Susceptibility of Donor MAC for H
Virus isolate MP BH
D117IIIb,c
Expt 1 1.02 3 103/ml 1.61 3 104/ml
Expt 2 2.33 3 103/ml 7.06 3 103/ml
Expt 3 ,4 3 102/ml 5.50 3 103/ml
ADA-Mb
Expt 1 2.91 3 102/ml 4.62 3 102/ml
Expt 2 ,5.8 3 102/ml 5.34 3 103/ml
BRUd
Expt 1 7.21 3 101/ml 7.27 3 101/ml
Expt 2 0.00/ml 4.4 3 102/ml
a Values for the 50% tissue culture infective dose (TCID50) are given
b M-tropic virus strain (R5).
c Three TCID50 values of four to eight individual experiments for eac
d T-tropic virus strain (X4).which remained at the same low level as shown in Fig. 2.
For testing the contribution of autocrine factors se-creted by the different donor MAC on HIV-1 infection of
these cells, we harvested 48-h supernatants of the re-
spective uninfected parallel MAC cultures of the most
divergent donors. These supernatants were added to the
corresponding HIV-1-infected homologous as well as
heterologous MAC (for details see Materials and Meth-
ods). If MAC of donor MP were incubated with either
homologous supernatant derived from the parallel unin-
fected MAC culture or heterologous supernatant derived
from uninfected cultures of KS’s MAC, the resulting RT
activities of both cultures remained at the same low level
(Fig. 5C). Correspondingly, the high level of RT activities
of KS’s MAC was unaltered when the cells were culti-
vated with supernatant derived from uninfected MAC of
donor MP. Therefore, neither activating nor suppressing
effects were exerted by the respective supernatants on
HIV-1 infection of the particular donor cells.
Donor-dependent infectibility of MAC is determined at
the level of HIV-1 reverse transcription
The pattern of HIV-1 DNA synthesis was compared in
MAC of individual donors. DNA of HIV-1-infected donor
MAC was isolated at different time points after infection
with HIV-1D117III or HIV-1ADA–M. Reverse transcription inter-
ediates which arise during RT reaction from HIV-1 RNA
o dsDNA were analyzed using specific PCR primers
quantification of the intermediates was performed as
escribed under Material and Methods). Figure 6 shows
he detection of HIV-1D117III DNA transcripts in the MAC of
donors KS and MP at different time points after infection.
Infected MAC of donors MP and KS showed comparable
amounts of the early transcripts (I), representing the R/U5
region, and of the intermediate transcripts (II), represent-
ing the R/PBS region, at days 1 and 5 p.i. (Fig. 6C). On
easured by TCID50 Determination
a
PR TK KS
2.80 3 104/ml 2.80 3 104/ml 1.44 3 105/ml
9.53 3 104/ml 9.30 3 103/ml 4.26 3 105/ml
2.34 3 104/ml 1.20 3 104/ml 1.20 3 106/ml
5.86 3 103/ml 4.65 3 103/ml 1.48 3 104/ml
2.20 3 103/ml 1.80 3 104/ml 2.30 3 103/ml
2.31 3 102/ml 2.91 3 102/ml 1.45 3 102/ml
1.25 3 100/ml 6.5 3 102/ml 0.00/ml
s titer per milliliter.
r are shown.ABLE 1
IV-1 M
as viruday 9 p.i., transcripts I and II sharply increased in MAC of
KS, whereas for MP no further increase of these tran-
sean flu
indep
36 EISERT ET AL.scripts was observed. For the other monocytotropic
HIV-1 isolate ADA-M a similar pattern was found, except
for intermediate transcript II in donor KS, which in-
creased as early as day 5 p.i. (Fig. 7).
However, a remarkable difference was found for full-
length HIV-1 DNA (III, R/gag region): whereas these tran-
scripts after infection with the isolate D117III were not
detected in MAC of donor MP, late-stage transcripts
increased over time in MAC of KS. The same difference
was observed when the cells were infected with HIV-
1ADA–M. In contrast to isolate D117III the full-length tran-
cript (III) of HIV-1ADA–M was detectable in MAC of donor
MP but the quantitative analysis revealed a much lower
copy number of full-length transcripts in cells of donor
MP compared to KS (Fig. 7). Thus, restriction of HIV-1
replication in MAC of MP occurs at an early postentry
FIG. 4. Antigen expression of MACs derived from different donors
monoclonal antibodies against CD4a, CCR3, CCR5, CXCR4, HLA-DR
determined by flow cytometry. Results of one experiment are given as m
for each donor, revealing similar results. (B) For antigen CD14 anotherstep as reflected by the absence (isolate D117III) or low
level (isolate ADA-M) of full-length viral DNA transcripts.In MAC of donors BH, PR, and TK reverse transcription
was completed and early transcripts, intermediate tran-
scripts, and full-length HIV-1 DNA were observed at
comparable copy numbers (data not shown).
DISCUSSION
Earlier in vitro studies by Williams and Cloyd have
shown that peripheral blood lymphocytes (PBL) from
some individual donors are more susceptible than others
to HIV-1 infection, with differences as much as 1000-fold.
In some instances, donor PBL even seemed to be com-
pletely resistant to infection with certain HIV-1 isolates
(Williams and Cloyd, 1991). Later, Spira and Ho reported
a 40-fold range of variability concerning infection of dif-
ferent donor PBL, which was substantially less than that
ells were harvested on day 7 after start of culture and stained with
, MAX.1 (CPM), and CD14. The expression of those antigens was
orescence intensity. Measurements were repeated three to five times
endent FACS analysis is shown.. (A) C
, CD16found by the first group (Spira and Ho, 1995). The authors
speculated that this discrepancy might be due to tech-
FIG. 5. Influence of soluble factors on HIV-1 infection of MO-derived MAC. (A) MO from donor KS and (B) donor MP were cultivated under the
influence of 100 ng/ml M-CSF, 10 ng/ml GM-CSF, 10 ng/ml IL-3, or a mixture of all three cytokines. On day 7 MO-derived MAC were infected with
HIV-1D117III and virus replication was monitored as described for Fig. 2. (C) Influence of potential autocrine factors secreted by MO-derived MAC into
cell culture supernatants on HIV-1 infection. Cells were infected with HIV-1D117III for 24 h on day 8 after start of culture. Culture supernatants of
uninfected MAC cultures form donors MP and KS were harvested every 48 h and used directly to cultivate the respective HIV-1-infected MAC from
the autologous (MP 1 supernatant MP and KS 1 supernatant KS) and heterologous (MP 1 supernatant KS and KS 1 supernatant MP) donors starting
1 day before infection. RT activities of the MAC cultures were measured on days 14 and 18 after start of culture.
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38 EISERT ET AL.nical reasons, as the viruses they used were derived
from short-term, low-passage-number cultures in PBMC.
For monocytes/macrophages there is growing evi-
dence that variation of HIV-1 infectibility as a function of
cell donor and the origin of the macrophages in the body
may exist. When the susceptibility of tissue macro-
phages isolated from healthy women was compared
with the corresponding autologous blood monocytes, in
some cases peritoneal macrophages showed signs of
infection much earlier than the autologous monocytes,
where in most cases lung macrophages failed to show
HIV-1 infection. The unexplained elevated infectibility of
peritoneal macrophages in a proportion of women did
not correlate with levels of CD4 antigen on these cells
(Olaffson et al., 1991).
In this study, MO/MAC derived from different donors
(n 5 30) were analyzed with respect to HIV-1 infectibility
and virus replication. Considerable donor-dependent dif-
ferences were found concerning total virus production as
well as the percentage of HIV-1-infected cells in the
individual cultures (Fig. 1). Five representative donors
were further analyzed in more detail. The replication
potential of a primary R5-tropic HIV-1 isolate in MO/MAC
FIG. 6. HIV-1 DNA intermediates during reverse transcription in MA
macrophages was used for PCR at days 1, 5, and 9 p.i. to amplify a 1
fragment of the R/PBS region (II, intermediate transcripts), and a 200-bp
fragment of the GAPDH gene was amplified. (B) 10-fold dilutions of DN
used for PCR (10–104 copies per reaction) with the respective primer p
of PCR products were analyzed densitometrically and were normalized
of three independent experiments is shown.of these selected donors ranged from undetectable (do-
nor MP) to high RT activities of up to 5 3 106 cpm/ml/90in (donor KS) at day 28 of cultivation. Low total virus
roduction in MAC of donor MP correlated with the
owest percentage of p24-positive cells in cultures de-
ived from this donor. However, virus production per
ingle infected MAC derived from the respective donors
as similar. Therefore, we conclude that the marked
ifferences in virus production between the donor cells
re due to variable numbers of infected cells.
In a cultivation system for blood-derived macrophages
hich is very similar to the one used in this study, Naif et
l. demonstrated host cell genetic effects influencing
IV-1 replication in MO/MAC (Naif et al., 1999). In a
omparison of p24 kinetics in MO/MAC derived from
airs of identical (ID) twins with those derived from URD,
irus kinetics and HIV-1 DNA levels that were signifi-
antly concordant were observed between the pairs of
D twins, but were discordant between URD pairs. From
hese results the authors concluded that the host cell
estriction to HIV-1 productive infection most likely oc-
urred prior to RT. However, host cell mechanisms acting
t stages following RT or a variable rate of viral spread in
he cultures cannot be excluded (Huang et al., 1993; Mori
t al., 1992; Sato et al., 1992; Toohey et al., 1995).
ifferent donors infected with HIV-1D117III. (A) HIV-1 DNA from 6 3 10
4
fragment of the R/U5 region of the LTR (I, early transcripts), a 156-bp
ent of the R/gag region (III, full-length transcripts). As control a 220-bp
8E5 cells containing one integrated copy of HIV-1 DNA per cell were
ed for the detection of the transcripts I–III (see above). (C) Intensities
DH reaction products given as relative intensities. One representativeC of d
40-bp
fragm
A from
airs us
to GAPAs a quantitative measurement for HIV-1 susceptibility
of donor MO/MAC we determined the TCID50 of M-tropic
w
H
s
nd give
39CELLULAR FACTORS INFLUENCING HIV-1 REPLICATIONvirus stocks on these cells, as has not been shown
before in the literature. TCID50 values of given virus
isolates differed by a factor of up to 3000 depending on
the donor cells used in the assay: values were highest
for cells from donor KS and lowest for cells from donor
MP. Consequently, further analysis was focused on early
events of viral entry and replication in MO/MAC. Cellular
factors which may influence directly viral entry into MO/
MAC are the natural receptors for HIV-1. Therefore, we
analyzed the expression of CD4 and CCR5 by flow cy-
tometry on the donor macrophages. In addition, the do-
nors were characterized genetically with respect to
CCR5 polymorphism. Today, it is evident that the homozy-
gous D32 deletion in the chemokine receptor CCR5, the
main coreceptor for HIV-1, leads to high resistance to
R5-tropic HIV-1 (Dean et al., 1996; Liu et al., 1996; Sam-
son et al., 1996). No homozygous individuals for this
deletion were found in our study. Moreover, we found
equal expression levels of the CCR5 protein on the cell
surface of all donors and there was no correlation be-
tween expression of CD4 receptor and HIV-1 infectibility
of the cells.
Soluble factors which may influence directly the infec-
tion of MO/MAC are the natural ligands for HIV-1 core-
ceptors (i.e., MIP-1a, MIP-1b, RANTES, and SDF-1).
Therefore, we analyzed the secretory potential of our
macrophages with respect to MIP-1a and RANTES,
hich are the major suppressive factors for M-tropic (R5)
IV-1 strains (Cocchi et al., 1995). No differences in
FIG. 7. HIV-1 DNA intermediates during reverse transcription in MA
macrophages was used for PCR at days 1, 5, and 9 p.i. to amplify early
control a 220-bp fragment of the GAPDH gene was amplified. (For d
densitometrically and were normalized to GAPDH reaction products aecretion of these b-chemokines were found comparing
the different donor cultures. Other secretory factorswhich might be released into the supernatants and sub-
sequently exert any enhancing or inhibitory effect on
HIV-1 infection of the donor MAC could be excluded by
adding supernatants derived from the most different do-
nor cells to the homologous and the heterologous mac-
rophages. In addition, hematopoietic growth factors M-
CSF, GM-CSF, and IL-3, for which MO/MAC have surface
receptors, did not stimulate virus replication in MAC
derived from donor MP. In concordance with other stud-
ies, however, MAC derived from donor KS treated with
M-CSF showed enhancement of virus replication (Gruber
et al., 1995), whereas HIV-1 production of these cells was
inhibited by GM-CSF and IL-3. An inhibitory effect of
GM-CSF on HIV-1 replication in MAC has recently been
reported by Kedzierska et al. (2000), whereas the effect of
IL-3 remains controversial in the literature (Koyanagi et
al., 1988; Matsuyama et al., 1991).
To further investigate the host-cell-specific properties
which may influence HIV-1 infectibility, we analyzed the
antigen expression on the donors’ MO/MAC since spe-
cific surface antigens reflect the maturation state of
these cells. Antigens like the low-affinity receptor for
immunoglobulin (CD16) or carboxypeptidase M/CPM
(also known as MAX.1 antigen) are weakly expressed on
freshly isolated MO and upregulated during mono-
cyte-to-macrophage differentiation (Andreesen et al.,
1986, 1988; Rehli et al., 1995). In some tissues macro-
phages the expression of CD14 is highly downregulated
compared to that on blood monocytes (Haugen et al.,
ifferent donors infected with HIV-1ADA–M. (A) HIV-1 DNA from 6 3 10
4
ripts (I), intermediate transcripts (II), and full-length transcripts (III). As
ee legend to Fig. 6). (B) Intensities of PCR products were analyzed
n as relative intensities.C of d
transc
etails s1998). Similar results were found in intestinal macro-
phages which even showed no CD14 expression (Smith
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40 EISERT ET AL.et al., 2000). It is known that successful MAC maturation
nfluences the susceptibility to infection by HIV-1. Auto-
ogous freshly isolated blood monocytes, monocyte-
erived MAC in culture, and alveolar MAC from healthy
ubjects were compared, showing that MO are less
usceptible to HIV-1 infection than alveolar macro-
hages and MO-derived MAC (Rich et al., 1992). Differ-
ences in the susceptibility of MAC of different donors to
HIV-1 infection could also reflect differences in the ca-
pacity of the donor MO to mature into MAC. Indeed,
donor MP always showed higher expression of the
MO/MAC antigen CD14, which is downregulated in some
tissue macrophages during maturation (Haugen et al.,
1998). To further confirm these findings we analyzed
MO/MAC derived from seven additional donors. Among
this group a donor with low virus replication in HIV-1-
infected macrophage cultures which correspondingly ex-
pressed the highest CD14 level could be identified (data
not shown). For the differentiation-dependent antigen
CPM (MAX.1) the correlation between expression level of
this antigen and HIV replication was equivocal and could
not be repeatedly confirmed. To further investigate dif-
ferences in maturation-related antigen expression levels
between individuals and comparison of HIV replication it
would be interesting to analyze antigen expression and
HIV-1 replication in differentiated tissue macrophages,
for example alveolar macrophages.
To further identify at which step downstream of viral
entry the donor differences are located, we compared
the pattern of HIV-1 DNA transcripts during reverse tran-
scription of the viral genome. Although the early and
intermediate transcripts (I and II) were present in similar
amounts in MAC of the most different donors MP and KS
early after infection, a remarkable difference was found
for full-length HIV-1 DNA transcripts (III) of HIV-1D117III,
which were not detectable in MAC of donor MP and
which were found at highly reduced level for HIV-1ADA–M.
he difference between D117III and ADA-M with respect
o detectability of late transcripts (III) may be due to the
ighly replicative capacity of ADA-M in MAC which led to
igher copy numbers (Gendelman et al., 1989). We con-
lude that the low infectibility of certain donor cells, like
P, could be explained by inefficient reverse transcrip-
ion, leading to restricted provirus formation and, conse-
uently, to low virus production in the culture. Alterna-
ively, it is conceivable that the stability and thus the
uantitity of the transcripts were altered in different do-
or MAC. In summary, our results support the hypothesis
hat host cell restrictions most probably occur during RT
rocesses, as could be shown by other studies suggest-
ng host genetic effects acting after binding to CD4 or
CR5 (Collman et al., 1990; Naif et al., 1998; O’Brien et al.,
990).
Low infectibility of MAC correlates with the restricted
ynthesis of full-length viral DNA after reverse transcrip-
ion in these cells. Decreased virus replication also cor-
8
selates with altered expression of MAC marker CD14 on
he cell surface. Therefore, it is conceivable that different
IV-1 infectibility is due to the generation of discernible
AC subpopulations during differentiation reflecting
ost genetic properties. Further analysis is needed to
efine the exact mechanism of restricted HIV-1 replica-
ion in certain MAC.
MATERIALS AND METHODS
iruses
For infection of MO-derived MAC, two monocytotropic
iruses and one lymphotropic virus were used. The
onocytotropic strain HIV-1D117III was a primary isolate
hich derived from a perinatally infected child (Ru¨bsa-
en-Waigmann et al., 1989). As control another monocy-
otropic strain, HIV-1ADA–M, and the lymphotropic HIV-1BRU
were used. The tropisms of the primary virus isolate and
HIV-1ADA–M were also characterized by determining the
coreceptor usage on U87MG cells: U87MG, U87MG-
CD4-CCR1, U87MG-CD4-CCR2b, U87MG-CD4-CCR3,
U87MG-CD4-CXCR4, and U87MG-CD4-CCR5 cells (3 3
105 per well) were seeded into a 24-cell plate for 1 day
nd then incubated with the HIV-1 strain for 24 h. Un-
ound virus was removed by two washes with culture
edium. Extracellular p24 antigen was measured 1, 7,
nd 14 days after infection. HIV-1D117III and HIV-1ADA–M
utilized CCR5 (R5 strains), and in addition ADA-M in-
fected the CCR3-expressing cell line. The other chemo-
kine receptors were not used as coreceptors by these
HIV-1 isolates. For the T-tropic reference isolate HIV-1BRU
it is known that it infects via CXCR4 (X4 strain) (Bazan et
al., 1998). HIV-1 virus stocks were obtained by propagat-
ing the lymphotropic virus in peripheral blood T cells and
the monocytotropic viruses in MAC cultures (von Briesen
et al., 1990). Cell-free culture supernatants at the peak of
infectivity were aliquoted and stored at 270°C.
Cell culture and HIV-1 infection
PBMC were separated from buffy coats or EDTA blood
of healthy HIV-1-seronegative male donors by density
gradient centrifugation over Ficoll–Hypaque. For gener-
ation of monocyte-derived macrophages the separated
PBMC were cultured on hydrophobic Teflon foils (Biofolie
25; Heraeaus, Hanau, Germany) for 7 days at a cell
density of 3 3 106 cells/ml in RPMI 1640 (Biochrom,
erlin, Germany) supplemented with antibiotics (100
/ml penicillin and 100 mg/ml streptomycin; Gibco, Ber-
lin, Germany), L-glutamine (2 mM; Gibco), and 4% pooled
human AB-group serum. After the indicated time period
cells were harvested and washed twice with RPMI 1640.
Viable cells were counted by trypan blue exclusion.
Mononuclear cells containing 4 3 105 (24-well plate) or
43 10 (96-well plate) MO-derived MAC/well were sub-
equently separated by adherence. After 1 h nonadher-
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41CELLULAR FACTORS INFLUENCING HIV-1 REPLICATIONent cells were removed by repeated washing and cells
were cultured with fresh medium. The remaining adher-
ent cell layer consisted of up to 95% MAC as determined
by morphology, nonspecific esterase staining, and CD14
expression. MO-derived MAC (4 3 105 in 2 ml medium)
were infected in 24-well plates on day 7 with 100 ml
HIV-1D117III with a reverse transcriptase activity of
,000,000 cpm/ml/90 min. After 24 to 48 h the virus
noculum was removed by washing the adherent cell
ayer several times. To test the influence of various cy-
okines on HIV-1 infection, cells were cultivated from day
in the presence of 100 ng/ml M-CSF (Cetus, Emeryville,
A), 10 ng/ml GM-CSF (Sandoz, Basal, Switzerland), 10
g/ml IL-3 (PeproTech, Rocky Hill, NJ), or a mixture of all
hree cytokines.
The influence of potential secretory factors released
y donor MAC into cell culture supernatant was tested
s follows: supernatants were collected from uninfected
onor MAC 48 h after medium exchange, cells and de-
ris were removed by centrifugation at 1400 rpm for 10
in. These supernatants were directly used to cultivate
he respective HIV-1-infected MAC derived from the au-
ologous and heterologous donors starting 1 day before
nfection. This procedure was repeated every 24 h.
etection and quantification of HIV-1 infection
Virus replication in donor MAC was assessed by HIV-1
24 antigen release using a commercially available en-
yme-linked immunosorbent assay (ELISA) kit (Innotest
IV Antigen mAb; Innogenetics, Zwijndrecht, Belgium) or
y measuring reverse transcriptase activity. At different
ime points, samples of 24-h supernatants were col-
ected and measured for RT activity as described (Ru¨b-
amen-Waigmann et al., 1986).
For detection of HIV-1 p24 antigen in situ, the infected
AC were washed with phosphate-buffered saline
PBS), fixed with 4% paraformaldehyde in PBS, and
tored in 70% ethanol at 220°C until use. After a wash
ith PBS, endogenous peroxidase activity was inhibited
y incubation with 1% H2O2. The nonspecific binding
capacities were blocked by 1.5% horse serum (Elite Vec-
tastain ABC Kit; Camon, Wiesbaden, Germany), followed
by incubation with mouse anti-HIV-1 p24 monoclonal
antibody (clon Kal-1; ScheBo-Tech, Wettenberg, Ger-
many) overnight at 4°C. As negative control (isotype
control) IgG1 was used (Dianova, Hamburg, Germany).
The cells were subsequently exposed to biotinylated
anti-mouse immunoglobulins (Elite Vectastain ABC Kit)
for 30 min, followed by incubation with avidin–biotiny-
lated horseradish peroxidase H complex (Elite Vec-
tastain ABC Kit) for 15 min. Finally the peroxidase reac-
tion was developed by incubation with AEC (Vectastain
AEC Kit; Camon, Wiesbaden, Germany), which resulted
in a red reaction product. For quantitation, positive and
negative MAC were counted at 200-fold magnification.
s
cAbout 800 cells were counted in different areas within
one well. If fewer than 100 positive cells per well existed,
the absolute number per well was counted. The mean of
parallel wells was determined.
TCID50 of different virus strains on MO-derived MAC
The three virus isolates described were titrated on
O-derived MAC. For determination of the TCID50 four-
fold dilutions of each virus strain were made. Donor MAC
were infected in 96-well plates with the virus dilutions in
sixfold replicates on day 7 for 24 h. After virus inocula-
tion, MAC were washed twice with medium, followed by
replacing the medium every 3–4 days. Ten days p.i. the
accumulated supernatant was stored for p24 antigen
determination and MAC were washed with PBS and
immunostained for p24 antigen as described above. The
number of wells with productively infected MAC was
determined by measuring p24 antigen using a commer-
cially available ELISA kit (Innotest HIV Antigen mAb;
Innogenetics) or by detection of HIV-1 p24 antigen in situ
by immunostaining. TCID50 was determined according to
pearman (1908) and Ka¨rber (1931).
CCR5 genotyping
DNA was extracted from donor PBMC using the
IAamp Blood Kit (Qiagen GmbH, Hilden, Germany) ac-
ording to the manufacturer’s instructions. PCR was per-
ormed by amplifying 547 (wild-type CCR5) or 515 (D32
eletion mutant of CCR5) bp of the coding region of the
CR5 gene with primers and reaction conditions de-
cribed elsewhere (Eugen-Olsen et al., 1997). The PCR
products were analyzed in a 2.0% agarose gel.
Flow cytometry
PBMC were used for FACS analysis on day 7 after start
of culture. Cells were washed twice with cold PBS con-
taining 0.1% sodium azide and 0.6 mg/ml bovine serum
albumin. Cells (1 3 106) were incubated with saturating
mounts of specific mAbs or IgG isotype control for 30
in at 4°C. The following antibodies were used: anti-
D14 (Coulter-Immunotech Diagnostics, Hamburg, Ger-
any), anti-CD16 (Dianova), anti-CPM/MAX.1 (our labo-
atory) (Andreesen et al., 1986), anti HLA-DR, anti-CD4
Immunotech), anti-CCR5 (clone 2D7), anti-CCR3 (clone
B11) (AIDS Research and Reference Program, see Ac-
nowledgments), and anti-CXCR4 (clone 12G5; R&D Sys-
ems GmbH, Wiesbaden, Germany). After two further
ashes, cells were incubated with saturating concentra-
ions of fluorescein isothiocyanate-conjugated goat anti-
ouse IgG for 30 min at 4°C. After two more washes
ells were fixed with 1% paraformaldehyde in PBS. Anal-
sis was performed using a FACScan (Becton–Dickin-
on). Cells were gated on the MO/MAC population ac-
ording to their forward and side scattering.
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42 EISERT ET AL.Detection of RANTES and MIP-1a in supernatants of
MO-derived MAC
Mononuclear cells of the different donors were plated
on 24-well plates on day 7 after isolation and MAC were
separated by adherence as described above. Twenty-
four-hour supernatants were harvested, filtered through
0.22-mm membranes (Millipore, Eschborn, Germany),
nd stored at 220°C for chemokine determinations.
ANTES and MIP-1a were measured by commercially
vailable ELISA (R&D Systems GmbH). As control 4%
erum-containing medium was tested and chemokine
evels were substracted.
uantification of HIV-1 DNA intermediates
DNA was prepared from uninfected and HIV-1-infected
AC at different time points after infection using the
IAamp Blood Kit (Qiagen GmbH) according to the man-
facturer’s instructions. For a single PCR, HIV-1 DNA
erived from 6 3 104 cells was amplified using 1.25 U Taq
olymerase (Boehringer, Mannheim, Germany) and reac-
ion conditions as previously described (Zack et al.,
990). Primers M667 and AA55 were used to amplify a
40-bp fragment of the R/U5 region of the LTR (I, early
ranscripts). A 156-bp fragment of the R/PBS region was
mplified by M667 in conjunction with BB301 (II, inter-
ediate transcripts). The formation of full-length viral
NA was detected by using M667 in conjunction with
661, which bind to R/gag sequences. The amplified
roduct is a 200-bp fragment (III, full-length HIV-1 DNA).
arallel reactions were performed with primers to am-
lify a 220-bp fragment of the GAPDH gene to ensure
hat equivalent amounts of DNA were analyzed in all
ases (Nottet et al., 1996). The reaction conditions for
APDH PCR were as follows: 50 mM KCl, 10 mM Tris–
Cl (pH 8.3), 2 mM MgCl2, 0.01% gelatin, 1.25 U Taq
polymerase, and 0.2 mM each of the four deoxyribo-
nucleoside triphosphates. Samples were subjected to 35
cycles of amplification (1 min at 94°C, 1 min at 60°C, and
1 min at 72°C, with a final extension at 72°C for 7 min).
For quantification of HIV-1 DNA from MAC, 10-fold dilu-
tions of extracted DNA from 8E5 cells containing one
integrated copy of HIV-1 DNA per cell were used for PCR
with the respective primer pairs (Folks et al., 1986). PCR
roducts were electrophoresed on a 1.5% agarose gel
nd visualized using ethidium bromide staining. Control
mplifications containing DNA of uninfected MAC or no
NA were always included and were negative in all
ases. Intensity of PCR products was analyzed densito-
etrically (with Gel Doc 2000 and Quantity One software,
io-Rad, Munich, Germany). Values were normalized to
APDH reaction products given as relative intensities.
mounts of various transcripts were calculated by com-
arison with the intensities of HIV-1 PCR products de-
ived from 8E5 cells.tatistical analysis
Between-donor differences with respect to virus repli-
ation kinetics were analyzed using the Friedman test,
hich is a nonparametric test. Statistical significance
as defined at P , 0.05 values (Sachs, 1992). The virus
roduction per single cell between different donors was
tatistically compared using unpaired Student’s t test
GraphPad software; San Diego, CA).
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